Document Detail


Minimizing Nuclear Medicine Technologist Radiation Exposure during 131I-MIBG Therapy.
MedLine Citation:
PMID:  23287519     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
ABSTRACT: I-metaiodobenzylguanidine is a norepinephrine analog that concentrates in adrenergic tissue and has been shown to be an effective radiotherapeutic agent used to treat tumors of neural crest origin, particularly neuroblastoma, a sympathetic nervous system malignancy of children. The purpose of this study was to determine the radiation dose received by nuclear medicine technologists while preparing and administering I-metaiodobenzylguanidine therapy dosages, and if any changes could be implemented that would reduce a technologist's dose. The study involves the collection of total whole body doses received by technologists during the treatment of six patients. Patient dosages ranged from 9.25 to 31.1 GBq, with radiation exposures to the nuclear medicine technologists averaging 0.024 μSv per MBq administered to the patient. Subsequently, the doses received by the technologists were analyzed with respect to specific process steps performed during I-metaiodobenzylguanidine therapy including package receipt, dosage preparation, and dosage administration. Results show that the largest contribution to the technologist's whole body radiation dose (>83%) is received during the dosage administration process step. After additional shielding was installed for use during the dosage administration process step, technologists' doses decreased 80%.
Authors:
Brian K Turpin; Victoria R Morris; Lisa Lemen; Brian D Weiss; Michael J Gelfand
Related Documents :
12850889 - Influence of a drink containing different antioxidants and lactobacillus plantarum 299v...
3705959 - Effect of magnesium deficiency on ultrastructural changes in coronary arteries of swine.
1381159 - Use of hypertonic saline/dextran versus lactated ringer's solution as a resuscitation f...
14690159 - Clodronate as a single-dose intravenous infusion effectively provides short-term correc...
24081439 - Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled tr...
23595199 - High-dose daptomycin monotherapy cures staphylococcus epidermidis 'endotipsitis' after ...
23212319 - No improvement in endurance performance after a single dose of beetroot juice.
25168659 - Low-dose glimepiride with sitagliptin improves glycemic control without dose-dependency...
10849569 - Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erect...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Health physics     Volume:  104     ISSN:  1538-5159     ISO Abbreviation:  Health Phys     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985093R     Medline TA:  Health Phys     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S43-6     Citation Subset:  IM    
Affiliation:
*University of Cincinnati, Cincinnati, OH.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Laser safety program at woods hole oceanographic institution.
Next Document:  Methodology for a bounding estimate of activation source-term.